CathRx sells first product to Europe

By Dylan Bushell-Embling
Wednesday, 17 September, 2008


CathRx [ASX: CXD] has secured the first sales of its diagnostic modular heart catheters to its UK distributor, in the company's first ever sale to Europe.

Cardiac catheters are minimally invasive tools widely used by specialist cardiologists to help diagnose and treat different types of cardiac arrhythmias.

The global market for cardiac catheters is predicted to be around $1.25 billion, with the European market alone worth $333.2 million.

CathRx plans to offer a progressively-expanding 'toolbox' of heart surgery tools to the European market in the next three quarters.

Related Articles

Aspirin could prevent some cancers from spreading

The research could lead to the targeted use of aspirin to prevent the spread of susceptible types...

Heat-induced heart disease is killing Australians

Hot weather is responsible for an average of almost 50,000 years of healthy life lost to...

Call for greater diversity in genomics research

A gene variant common in Oceanian communities has been misclassified as a potential cause of...


  • All content Copyright © 2025 Westwick-Farrow Pty Ltd